Freeport-McMoRan Inc. (NYSE:FCX) maintained as Buy but the target price was cut to 19 from 23 at Jefferies. The firm is concerned that negotiations between FCX and Indonesia regarding the sale of a majority stake in PT-FI to locals have become more contentious.
Gilead Sciences Inc. (NASDAQ:GILD) analysts reinstated with a Hold rating and was given a 93 target price at Jefferies. Still, the firm has a fundamental positive and underlying view that KITE Axi-cel sales will get off to a good start and build some momentum while investors wait to see how HCV volumes and prices settle out in 2-H of this year.
Oracle Corp. (NYSE:ORCL) started with an Overweight rating and assigned a 55 price target at Piper Jaffray. Oracle has a 52-wk trading range of 37.62 – 53.14 and a consensus price target of 56.52.
Tesla Inc. (NASDAQ:TSLA) analysts started with a Buy rating and assigned a 500 price target at Nomura, which is way above the prior street-high analyst target price of 464 and compares to a prior closing price of 348.14. Tesla has a 52-wk range of 178.19 – 389.61, and it previously had a consensus price target of 318.63. HeffX-LTN rates TSLA as a sell with a 250/share target price.
Latest posts by Paul Ebeling (see all)
- Wall Street’s Key Stock Analysts Research Report, All Buys - March 30, 2020
- Commentary: Paul Ebeling on Wall Street, World Vs Coronavirus - March 30, 2020
- Gold: Conditions Setting Up for the Price to 2X - March 30, 2020